While disagreeing with Justice Varma’s challenge on key points, the court noted “some infirmity” in how the panel was formed and will examine whether it warrants intervention under Article 32.

Outlook Therapeutics' stock fell to a new low due to FDA rejection of its Lytenava filing for wet AMD. Efficacy evidence ...

Igor Shesterkin was placed on injured reserve, while Adam Fox was placed back on long-term injured reserve. In the first ...

By halting the Sotheby’s auction of rare Piprawah Gems, sacred Buddhist relics excavated in 1898 in Uttar Pradesh, India is looking to reach out to Buddhist majority countries across the world.

The FDA issued a CRL for ONS-5010, citing the need for additional confirmatory efficacy evidence despite previous trials ...

Here in the Northeast, we've seen two clipper systems in the past three days, but the weather pattern is about to change.

Nio stock price remains in a deep bear market this year after falling by ~40% from its highest point this year.

After her 2022 Beijing Olympics debut, the champion figure skater shocked the world with a retirement announcement when she ...

The report released recently by the Delhi government's Directorate of Economics and Statistics covered the budgets of three ...

Year Increase of 13% in Revenues and 23% in Adjusted EBITDA Based on Mid-Point of 2025 Annual Guidance2026 Annual Guidance is ...

Most people in 1998 correctly doubted that space travel would be common for ordinary Americans or that alien life forms would ...

Outlook Therapeutics ( (OTLK) ) has shared an update.